Organization and Description of Business (Details Narrative) |
3 Months Ended | 6 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 25, 2024
USD ($)
shares
|
Jul. 17, 2024
USD ($)
|
Jun. 14, 2024
USD ($)
|
May 20, 2024
USD ($)
$ / shares
shares
|
May 14, 2024
USD ($)
|
Apr. 05, 2024
USD ($)
$ / shares
|
Mar. 31, 2024
USD ($)
|
Feb. 23, 2024 |
Feb. 14, 2024
shares
|
Feb. 13, 2024
shares
|
Nov. 13, 2023
USD ($)
|
Feb. 21, 2023
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
$ / shares
shares
|
Jun. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
shares
|
Jun. 30, 2024
USD ($)
$ / shares
shares
|
Jun. 30, 2023
USD ($)
|
Jul. 24, 2024
shares
|
Jun. 17, 2024
shares
|
Mar. 04, 2024
$ / shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
Feb. 28, 2023
$ / shares
shares
|
|
| Common stock, par value | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||
| Reverse Stock Split | 1-for-30 | 1-for-30 | ||||||||||||||||||||
| Common stock issued | shares | 16,666,666 | 500,000,000 | ||||||||||||||||||||
| Common stock, shares authorized | shares | 66,666,666 | 550,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | |||||||||||||||||
| Preferred stock, par value | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||
| Issuance of preferred shares | $ 5,100,000 | |||||||||||||||||||||
| Preferred stock dividends | 625,382 | $ 373,796 | $ 1,827,249 | $ 532,129 | ||||||||||||||||||
| Derivative fair value | $ 3,149,800 | 0 | 0 | |||||||||||||||||||
| Stock issuance costs | 314,311 | |||||||||||||||||||||
| Fair value of the warrants | $ 10,623,000 | |||||||||||||||||||||
| Change in fair value of derivative liability | $ (72,000) | (1,490,200) | $ (11,000) | (315,200) | ||||||||||||||||||
| Probability of default | 1.5 | 1.5 | ||||||||||||||||||||
| Fair value of the warrants | 10,623,000 | |||||||||||||||||||||
| Issuance of warrants | 762,834 | |||||||||||||||||||||
| Warrants at fair value | $ (2,701,000) | (2,930,700) | $ 4,393,000 | (2,810,000) | ||||||||||||||||||
| Preferred Stock, Shares Authorized | shares | 50,000,000 | 50,000,000 | 50,000,000 | |||||||||||||||||||
| Employment agreement description | Effective November 13, 2023, the Company entered into an amendment to the employment agreement of Dr. Chris Chapman, its President and Chief Medical Officer, providing for Dr. Chapman’s annual base salary to be adjusted from five hundred thousand dollars ($500,000) (the “Full Base Salary”) to two hundred fifty thousand dollars ($250,000) in cash per annum, until payment of his Full Base Salary would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion. The amendment further provides that the remaining $250,000 of base salary per annum (the “Deferral Amount”) shall be deferred until payment of the Deferral Amount would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion, at which time the Deferral Amount may be paid, at Dr. Chapman’s election, in shares of Common Stock or in cash. As of June 30, 2024 and December 31, 2023, the Company had recognized a salary deferral of $120,192 and $28,846, respectively, which was paid to Dr. Chapman upon his separation from the Company. | |||||||||||||||||||||
| Officers compensation | $ 345,056 | 559,224 | ||||||||||||||||||||
| Implementation of directors agreement description | In connection with an overall reduction in compensation paid to the Company’s directors implemented in November 2023, effective November 13, 2023, the Company entered into an amendment to the employment agreement of Christopher C. Schreiber, a Director and the Company’s former Executive Chairman, providing for Mr. Schreiber’s annual fee to be adjusted from three hundred thousand dollars ($300,000) (the “Full Fee”) to sixty thousand dollars ($60,000) in cash per annum, until payment of his Full Fee would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion. The amendment further provides that the remaining $240,000 of the fees per annum (the “Fee Deferral Amount”) shall be deferred until payment of the Fee Deferral Amount would no longer jeopardize the Company’s ability to continue as a going concern, as determined by the Company in its sole discretion, at which time the Fee Deferral Amount may be paid, at Mr. Schreiber’s election, in shares of Common Stock or in cash. The amendment also clarified that Mr. Schreiber’s title is “Director.” As of June 30, 2024 and December 31, 2023, the Company had recognized a salary deferral of $120,000 and $27,692, respectively, which is included in Deferred Compensation Payable on the Condensed Consolidated Balance Sheets. | |||||||||||||||||||||
| Board fee deferral | $ 331,992 | 331,992 | ||||||||||||||||||||
| Deferred Compensation Payable [Member] | ||||||||||||||||||||||
| Board fee deferral | $ 140,800 | $ 140,800 | $ 44,000 | |||||||||||||||||||
| Series F-1 Short Term Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Warrants to purchase common stock | shares | 2,780,839 | 2,780,839 | ||||||||||||||||||||
| Series F-1 Long Term Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Warrants to purchase common stock | shares | 2,780,839 | 2,780,839 | ||||||||||||||||||||
| Series F-1 Long Term Warrants [Member] | Subsequent Event [Member] | ||||||||||||||||||||||
| Warrants at fair value | $ 6,965,000 | |||||||||||||||||||||
| Change in fair value as a non-cash loss | 16,000 | |||||||||||||||||||||
| Series G Short Term Warrants [Member] | Subsequent Event [Member] | ||||||||||||||||||||||
| Warrants at fair value | 12,343,000 | |||||||||||||||||||||
| Change in fair value as a non-cash loss | $ 11,000 | |||||||||||||||||||||
| Fair Value, Recurring [Member] | ||||||||||||||||||||||
| Fair value of the warrants | $ 21,992,000 | |||||||||||||||||||||
| Change in fair value of derivative liability | 11,000 | |||||||||||||||||||||
| Warrants at fair value | 4,393,000 | |||||||||||||||||||||
| Reclassification of warrant liability to equit upon warrant modification | (7,961,000) | |||||||||||||||||||||
| Other Operating Income (Expense) [Member] | ||||||||||||||||||||||
| Change in fair value of derivative liability | $ 0 | 194,500 | $ 0 | 315,200 | ||||||||||||||||||
| Fair value of common stock on valuation date | $ / shares | $ 2.39 | $ 2.39 | ||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||
| Common stock issued | shares | 65,960 | |||||||||||||||||||||
| Issuance of preferred shares | ||||||||||||||||||||||
| Exercise price | $ / shares | $ 1.84 | $ 1.84 | $ 7.77 | |||||||||||||||||||
| Preferred Stock [Member] | ||||||||||||||||||||||
| Issuance of preferred shares | 14,087,111 | |||||||||||||||||||||
| Derivative fair value | 3,149,800 | |||||||||||||||||||||
| Contra Preferred Stock [Member] | ||||||||||||||||||||||
| Issuance of preferred shares | 9,000,000.0 | |||||||||||||||||||||
| Measurement Input, Expected Dividend Rate [Member] | ||||||||||||||||||||||
| Derivative measurement input | 10.0 | 10.0 | 10.0 | |||||||||||||||||||
| Estimated equity volatility | 95.00% | |||||||||||||||||||||
| Discounted market interest rate | 6.20% | |||||||||||||||||||||
| Penalty dividend rate | 15.0 | 15.0 | ||||||||||||||||||||
| Measurement Input, Exercise Price [Member] | Common Stock [Member] | ||||||||||||||||||||||
| Exercise price | $ / shares | $ 1.90 | |||||||||||||||||||||
| Measurement Input, Option Volatility [Member] | ||||||||||||||||||||||
| Derivative measurement input | 120.0 | |||||||||||||||||||||
| Measurement Input, Price Volatility [Member] | ||||||||||||||||||||||
| Derivative measurement input | 190.0 | |||||||||||||||||||||
| Measurement Input, Maturity [Member] | ||||||||||||||||||||||
| Time of maturity | 1 year 4 months 6 days | |||||||||||||||||||||
| Measurement Input, Maturity [Member] | Other Operating Income (Expense) [Member] | ||||||||||||||||||||||
| Time of maturity | 3 months | |||||||||||||||||||||
| Measurement Input, Discount Rate [Member] | ||||||||||||||||||||||
| Derivative measurement input | 6.8 | |||||||||||||||||||||
| Measurement Input, Lapse Rate [Member] | ||||||||||||||||||||||
| Derivative measurement input | 15.0 | |||||||||||||||||||||
| Measurement Input, Default Rate [Member] | ||||||||||||||||||||||
| Derivative measurement input | 0.5 | |||||||||||||||||||||
| Measurement Input Volume Volatility [Member] | ||||||||||||||||||||||
| Estimated traded volume volatility | 175.0 | 175.0 | ||||||||||||||||||||
| Series F Convertible Preferred Stock [Member] | ||||||||||||||||||||||
| Conversion price | $ / shares | $ 2.255 | |||||||||||||||||||||
| Share issued price, per share | $ / shares | $ 6.765 | |||||||||||||||||||||
| Issuance of preferred shares | $ 3,000,000 | |||||||||||||||||||||
| Preferred shares dividend rate | 10.00% | |||||||||||||||||||||
| Preferred stock conversion ratio percentage | 19.99 | 19.99 | ||||||||||||||||||||
| Series F Convertible Preferred Stock [Member] | Preferred Stock [Member] | ||||||||||||||||||||||
| Issuance of preferred shares | 912,889 | |||||||||||||||||||||
| Series F Convertible Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member] | ||||||||||||||||||||||
| Preferred shares dividend rate | 15.00% | |||||||||||||||||||||
| Series F-1 Preferred Stock [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Debt description | The amortization payments due upon such redemption are payable, at the Company’s election, in cash, or subject to certain limitations, in shares of Common Stock valued at the lower of (i) the Series F Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Series F Common Stock during the thirty trading day period immediately prior to the date the amortization payment is due or (B) a “Floor Price” of $6.60 on a post-split basis (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market. | |||||||||||||||||||||
| Preferred shares dividend rate | 10.00% | |||||||||||||||||||||
| Preferred stock dividends | $ 54,813 | 0 | $ 54,813 | 0 | ||||||||||||||||||
| Warrants at fair value | 7,900,000 | |||||||||||||||||||||
| Fair value, preferred stock | 9,300,000 | |||||||||||||||||||||
| Derivative liability | 900,000 | 900,000 | ||||||||||||||||||||
| Stock discount | $ 5,100,000 | |||||||||||||||||||||
| Preferred stock stock description | (i) approximately $4.2 million related to the difference between the gross proceeds and the allocated residual fair value of the Series F-1 Preferred Stock (i.e., $0), and (ii) approximately $0.9 million related to the stock derivative at issuance, is accounted for as a reduction to the carrying value of the Series F Preferred Stock and will be accreted from the issuance date to maturity in accordance with ASC 480-10-S99-3A as redemption is deemed probable pursuant to the Installment Redemption terms of the Series F-1 Certificate of Designations. | |||||||||||||||||||||
| Series F-1 Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member] | ||||||||||||||||||||||
| Preferred shares dividend rate | 15.00% | |||||||||||||||||||||
| Series G Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred shares dividend rate | 10.00% | |||||||||||||||||||||
| Preferred stock dividends | 97,145 | 0 | $ 97,145 | 0 | ||||||||||||||||||
| Series G Preferred Stock [Member] | Preferred Stock [Member] | ||||||||||||||||||||||
| Warrants at fair value | 14,100,000 | |||||||||||||||||||||
| Fair value, preferred stock | $ 22,300,000 | |||||||||||||||||||||
| Series G Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member] | ||||||||||||||||||||||
| Preferred shares dividend rate | 15.00% | |||||||||||||||||||||
| Series F Common Stock Warrants [Member] | ||||||||||||||||||||||
| Fair value of the warrants | $ 10,623,000 | |||||||||||||||||||||
| Series F Common Stock Warrants [Member] | Warrant [Member] | ||||||||||||||||||||||
| Warrants term | 5 years | |||||||||||||||||||||
| Series F Common Stock Warrants [Member] | Measurement Input, Option Volatility [Member] | ||||||||||||||||||||||
| Stock price per share | 125.0 | |||||||||||||||||||||
| Series F Common Stock Warrants [Member] | Measurement Input, Expected Dividend Payment [Member] | ||||||||||||||||||||||
| Stock price per share | 0 | |||||||||||||||||||||
| Series F Common Stock Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||||||||||||||||||||||
| Stock price per share | 4.09 | |||||||||||||||||||||
| Series F Warrants [Member] | ||||||||||||||||||||||
| Fair value of the warrants | $ 7,961,000 | |||||||||||||||||||||
| Series F Warrants [Member] | Fair Value, Recurring [Member] | ||||||||||||||||||||||
| Warrant liability | $ 7,961,000 | $ 7,094,000 | ||||||||||||||||||||
| Reclassification of warrant liability to equit upon warrant modification | $ 7,961,000 | |||||||||||||||||||||
| Series F Warrants [Member] | Other Operating Income (Expense) [Member] | ||||||||||||||||||||||
| Warrants at fair value | $ 0 | $ 1,635,000 | $ 7,094,000 | $ 315,200 | ||||||||||||||||||
| Series F Warrants [Member] | Warrant [Member] | ||||||||||||||||||||||
| Warrants term | 3 years 10 months 24 days | 3 years 10 months 24 days | ||||||||||||||||||||
| Series F Warrants [Member] | Measurement Input, Option Volatility [Member] | ||||||||||||||||||||||
| Stock price per share | 110.0 | 110.0 | ||||||||||||||||||||
| Series F Warrants [Member] | Measurement Input, Expected Dividend Payment [Member] | ||||||||||||||||||||||
| Stock price per share | 0 | 0 | ||||||||||||||||||||
| Series F Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||||||||||||||||||||||
| Stock price per share | 4.31 | 4.31 | ||||||||||||||||||||
| Series F One Preferreds Stock [Member] | ||||||||||||||||||||||
| Debt description | The amortization payments due upon such redemption are payable, at the Company’s election, in cash at 105% of the applicable Installment Redemption Amount (as defined in the Series F-1 Certificate of Designations), or subject to certain limitations, in shares of Common Stock valued at the lower of (i) the Series F-1 Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Common Stock during the thirty consecutive trading day period ending and including the trading day immediately prior to the date the amortization payment is due or (B) $0.364, which is 20% of the “Minimum Price” (as defined in Nasdaq Stock Market Rule 5635) on the date in which the Series F-1 Stockholder Approval (as defined herein) was obtained or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Capital Market, and, in each case, subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events, which amortization amounts are subject to certain adjustments as set forth in the Series F-1 Certificate of Designations (the “Series F-1 Floor Price”). | |||||||||||||||||||||
| Series G Convertible Preferred Stock [Member] | Preferred Stock [Member] | ||||||||||||||||||||||
| Issuance of preferred shares | ||||||||||||||||||||||
| Investors [Member] | Warrant [Member] | Series G Short Term Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Warrants to purchase common stock | shares | 4,928,416 | 4,928,416 | ||||||||||||||||||||
| Investors [Member] | Warrant [Member] | Series G Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Warrants to purchase common stock | shares | 4,928,416 | 4,928,416 | ||||||||||||||||||||
| Director [Member] | ||||||||||||||||||||||
| Deferral excess payment | $ 156,000 | |||||||||||||||||||||
| Eagle Uzonwanne [Member] | ||||||||||||||||||||||
| Deferral excess payment | 36,000 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | ||||||||||||||||||||||
| shares issued | shares | 5,050 | |||||||||||||||||||||
| Convertable preferred stock | shares | 2,780,839 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Preferred stock, stated value | $ / shares | $ 1,000 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Series F-1 Short Term Warrants [Member] | ||||||||||||||||||||||
| Issuance of warrants | $ 2,780,839 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Series F-1 Long Term Warrants [Member] | ||||||||||||||||||||||
| Issuance of warrants | $ 2,780,839 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Series F-1 Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred stock, par value | $ / shares | 0.001 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Series G Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred stock, par value | $ / shares | $ 0.001 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | ||||||||||||||||||||||
| shares issued | shares | 15,000 | |||||||||||||||||||||
| Preferred stock stated value | $ 1,000 | |||||||||||||||||||||
| Convertable preferred stock | shares | 6,651,885 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 2.255 | $ 3.18 | ||||||||||||||||||||
| Issuance of warrants | $ 6,651,885 | |||||||||||||||||||||
| Preferred stock, par value | $ / shares | $ 3.18 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 3.18 | |||||||||||||||||||||
| Warrants to purchase common stock | shares | 4,716,904 | 4,716,904 | ||||||||||||||||||||
| Stock issuable | shares | 8,259,911 | 8,259,911 | ||||||||||||||||||||
| Conversion price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Warrants term | 5 years | 5 years | 5 years | |||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Series G Short Term Warrants [Member] | ||||||||||||||||||||||
| Issuance of warrants | $ 4,928,416 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Series G Long Term Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Issuance of warrants | $ 4,928,416 | |||||||||||||||||||||
| Issuance of warrants | $ 4,928,416 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Common Stock [Member] | ||||||||||||||||||||||
| Warrants to purchase common stock | shares | 4,716,904 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Series F Preferred Stock [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | 1.816 | |||||||||||||||||||||
| Preferred stock, par value | $ / shares | 1.816 | |||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Series G Preferred Stock [Member] | ||||||||||||||||||||||
| shares issued | shares | 8,950 | |||||||||||||||||||||
| Convertable preferred stock | shares | 4,928,416 | |||||||||||||||||||||
| Warrant exercise price | $ / shares | 1.816 | |||||||||||||||||||||
| Conversion price | $ / shares | $ 1.816 | $ 1.816 | ||||||||||||||||||||
| Securities Purchase Agreement [Member] | Investors [Member] | Series F Common Stock Warrants [Member] | ||||||||||||||||||||||
| Warrant exercise price | $ / shares | $ 1.816 | |||||||||||||||||||||
| Series G Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred stock, stated value | $ / shares | $ 1,000 | |||||||||||||||||||||
| Series F-1 Registration Rights Agreement [Member] | ||||||||||||||||||||||
| Series F-1 registration rights description | the Company entered into a Registration Rights Agreement with the Series F-1 Investors (the “Series F-1 Registration Rights Agreement,”), pursuant to which the Company agreed to file a resale registration statement (the “Series F-1 Registration Statement”) with the SEC to register for resale 200% of the Series F-1 Conversion Shares and (B) 200% of the Series F-1 Warrant Shares promptly following the Closing Date, but in no event later than 30 calendar days after the Closing Date, and to have such Series F-1 Registration Statement declared effective by the Effectiveness Deadline (as defined in the Series F-1 Registration Rights Agreement). | |||||||||||||||||||||
| Series G Registration Rights Agreement [Member] | ||||||||||||||||||||||
| Series F-1 registration rights description | the Company entered into a Registration Rights Agreement with the Series G Investors (the “Series G Registration Rights Agreement” and, together with the Series F-1 Registration Rights Agreement, the “Registration Rights Agreements”) pursuant to which the Company agreed to file a resale registration statement (the “Series G Registration Statement”) with the SEC to register for resale 200% of the Series G Conversion Shares, (B) 200% of the shares of Common Stock issuable upon conversion of the PIK Shares, and (C) 200% of the Series G Warrant Shares promptly following the Closing Date, but in no event later than 30 calendar days after the Closing Date, and to have such Series G Registration Statement declared effective by the Effectiveness Deadline (as defined in the Series G Registration Rights Agreement) | |||||||||||||||||||||
| Gpn agreement [Member] | Series F Warrants [Member] | ||||||||||||||||||||||
| Private Placement Warrants Description | In connection with the Private Placements, pursuant to (A) an engagement letter (the “GPN Agreement”) with GP Nurmenkari Inc. (“GPN”) and (B) an engagement letter (the “Palladium Agreement,” and collectively with the GPN Agreement, the “Engagement Letters”) with Palladium Capital Group, LLC (“Palladium,” and collectively with GPN, the “Placement Agents”), the Company engaged the Placement Agents to act as non-exclusive placement agents in connection with each Private Placement, pursuant to which, the Company agreed to (i) pay the Placement Agents a cash fee equal to 3% of the gross proceeds of each Private Placement (including any cash proceeds realized by the Company from the exercise of the Series F Warrants), (ii) reimbursement and payment of certain expenses, and (iii) issue to the Placement Agents on the Closing Date, warrants to purchase up to an aggregate of 693,833 of shares of Common Stock to each Placement Agent, which is equal to 3% of the aggregate number of shares of Common Stock underlying the securities issued in each Private Placement, including upon exercise of any Series F Warrants, with terms identical to the Series G Long-Term Warrants and Series F-1 Long-Term Warrants. | |||||||||||||||||||||
| Separation Agreement [Member] | ||||||||||||||||||||||
| Officers compensation | $ 125,000 | |||||||||||||||||||||
| Payments to officer | 25,000 | |||||||||||||||||||||
| Salaries | 150,000 | |||||||||||||||||||||
| Share based compensation | $ 197,427 | |||||||||||||||||||||
| Minimum [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 16,666,666 | |||||||||||||||||||||
| Minimum [Member] | Subsequent Event [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 16,666,666 | |||||||||||||||||||||
| Minimum [Member] | Series F Convertible Preferred Stock [Member] | ||||||||||||||||||||||
| Conversion price | $ / shares | $ 60.21 | 60.21 | $ 60.21 | |||||||||||||||||||
| Minimum [Member] | Series F-1 Preferred Stock [Member] | ||||||||||||||||||||||
| Conversion price | $ / shares | 2.253 | 2.253 | ||||||||||||||||||||
| Minimum [Member] | Series G Preferred Stock [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 8,950 | |||||||||||||||||||||
| Conversion price | $ / shares | $ 2.253 | $ 2.253 | ||||||||||||||||||||
| Minimum [Member] | Director [Member] | ||||||||||||||||||||||
| Director fees | 60,000 | |||||||||||||||||||||
| Minimum [Member] | Eagle Uzonwanne [Member] | ||||||||||||||||||||||
| Director fees | 60,000 | |||||||||||||||||||||
| Minimum [Member] | Amendment Agreement [Member] | Series G Convertible Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred Stock, Shares Authorized | shares | 8,950 | |||||||||||||||||||||
| Maximum [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 250,000,000 | |||||||||||||||||||||
| Maximum [Member] | Subsequent Event [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 250,000,000 | |||||||||||||||||||||
| Maximum [Member] | Common Stock [Member] | ||||||||||||||||||||||
| Preferred stock conversion ratio percentage | 19.99 | 19.99 | ||||||||||||||||||||
| Maximum [Member] | Series G Preferred Stock [Member] | ||||||||||||||||||||||
| Common stock, shares authorized | shares | 12,826,273 | |||||||||||||||||||||
| Maximum [Member] | Director [Member] | ||||||||||||||||||||||
| Director fees | 216,000 | |||||||||||||||||||||
| Maximum [Member] | Eagle Uzonwanne [Member] | ||||||||||||||||||||||
| Director fees | $ 96,000 | |||||||||||||||||||||
| Maximum [Member] | Amendment Agreement [Member] | Series G Convertible Preferred Stock [Member] | ||||||||||||||||||||||
| Preferred Stock, Shares Authorized | shares | 12,826,273 | |||||||||||||||||||||